Pfizer standalone net profit rises 117.61% in the September 2022 quarter
Sales rise 0.19% to Rs 637.47 crore
Net profit of Pfizer rose 117.61% to Rs 311.07 crore in the quarter ended September 2022 as against Rs 142.95 crore during the previous quarter ended September 2021. Sales rose 0.19% to Rs 637.47 crore in the quarter ended September 2022 as against Rs 636.26 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales637.47636.26 0 OPM %36.3529.76 -PBDT252.55202.19 25 PBT226.30174.96 29 NP311.07142.95 118Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 12 2022 | 8:02 AM IST